Germany – Pharmaceutical products – Open-House-Rabattverträge 2025-14 - Guanfacin (RET, Wirkstärken: 1-4 mg)
openTechniker Krankenkasse · 992-80116-93
Value
unstated
Published
9 Oct 2025
Deadline
31 Oct 2026, 22:58 GMT · 7d left · as published, verify on the notice
Type
opportunity
33600000 · Medical equipment, pharmaceuticals & personal careDE600
Description
Die Krankenkassen verfolgen das Ziel, mit allen geeigneten pharmazeutischen Unternehmern Rabattverträge nach § 130a Abs. 8 SGB V über die im jeweiligen Los genannten Wirkstoffe, Wirkstoffkombinationen bzw. Darreichungsformen, Wirkstärken oder Fertigarzneimittel zu schließen.
Key facts
- Procedure
- open
- Contact
- DZEM@tk.de
- Contract period
- 1 Nov 2025 → 31 Oct 2026
- Category
- supplies
What a subscription adds to this notice
- The documents — every attachment, with its text extracted and searchable
- Qualification — the notice scored against your company profile
- Tracking and alerts — a pipeline for your bids, and the matching notices by email
- Calendar export — the deadline as a calendar file
- The API and MCP — the same record in your own tools and your AI assistant
Provenance
- Source
- ted-eu
- Notice id
- 664415-2025
- First seen
- 22 Aug 2026
- Last updated
- 22 Aug 2026
Licence EU reuse — Commission Decision 2011/833/EU ↗
Source: TED — Tenders Electronic Daily (ted.europa.eu), © European Union, reused under Commission Decision 2011/833/EU.
View at source ↗
GET /api/v1/tenders/043fdba7-0a0c-405d-8113-d6f4049e12dfThe source notice is authoritative — verify deadlines and documents there before bidding.